In a groundbreaking move, the Alzheimer’s Association recommends blood tests for diagnosing cognitive impairment, potentially increasing access to treatment. This could revolutionize how Alzheimer's is diagnosed, especially in rural areas.
A groundbreaking technique from the University of Glasgow enables non-invasive brain imaging by shining light through the head, promising deeper insights into brain health and conditions like strokes and tumors.
A new NIH-funded study reveals crucial protein changes in spinal fluid that may provide the first specific biomarkers for frontotemporal dementia (FTD), paving the way for earlier diagnosis and treatment options.
A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
